JCI vs EMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 11, 2026

JCI

61.1
AI Score
VS
JCI Wins

EMR

55.5
AI Score

Investment Advisor Scores

JCI

61score
Recommendation
BUY

EMR

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric JCI EMR Winner
Forward P/E 30.303 21.2314 EMR
PEG Ratio 2.5976 1.7687 EMR
Revenue Growth 8.2% 2.9% JCI
Earnings Growth 38.9% 27.9% JCI
Tradestie Score 61.1/100 55.5/100 JCI
Profit Margin 14.4% 13.4% JCI
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD JCI

Frequently Asked Questions

Based on our detailed analysis, JCI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.